The BioAsia Convention 2024

Blog Credit: Trupti Thakur

Image Courtesy: Google

The Bio Asia Convention – 2024

The 21st edition of BioAsia, Asia’s premier biotechnology and life sciences convention began  in Hyderabad, India. The annual event witnesses participation from leading global scientists, researchers, politicians and industry captains discussing latest developments and future opportunities.

About BioAsia

The flagship initiative started in 2003 by Government of Telangana, it has become a leading ideas exchange platform at the intersection of scientific research and business bringing together diverse stakeholders from pharma giants to startups.

2024 Edition Theme

The theme for current year summit is “Transforming Life Sciences with Data and AI” highlighting the immense potential in deploying advanced analytics alongside machine learning promises for revolutionizing drug discovery, healthcare delivery etc through evidence based interventions.

Inaugural Session Proceedings

The opening session witnessed keynote addresses from Nobel Laureate Gregg Semenza, Bristol Myers Squibb CEO Christopher Boerner and Providence health network head Rodney Hochman setting stage for deliberations around harnessing cross domain synergies.

Strategic Focus Areas

With over 50 countries participation, multiple tracks have been designed covering pharmaceutical innovations, medtech advances, investment roadmapping, data powered R&D etc where industry thought leaders would discuss ideas furthering affordable and accessible solutions.

Wider Engagement Platform

Alongside main conference, BioAsia offers specially curated workshops, exhibition arena for cutting edge products display from young ventures, B2B meeting spaces, lab/facility visits like Genome Valley tour etc facilitating greater engagement.

India’s Growing Biotech Reputation

Experts noted that events like BioAsia have remarkably enhanced Hyderabad’s brand as India’s lifesciences capital second only to Boston or San Francisco globally with robust talent base, high quality infrastructure, proactive policies and ease-of-doing research transforming regional ecosystem.

Collaboration with the Centre

BioAsia 2024 has teamed up with the Ministry of Micro, Small, and Medium Enterprises (MSME) to provide support to micro, small and medium (MSME) sector.
With a dedicated MSME Pavilion, featuring leading companies from the sector, BioAsia 2024 offers an opportunity for MSMEs to make key partnerships, expand their businesses and showcase India’s prowess in the global life sciences arena.

The 21st edition of the premier life sciences and healthcare forum in Asia, where innovation, data, and artificial intelligence converge to redefine possibilities. Held in the thriving city of Hyderabad, India, from February 26-28, 2024 with the theme of “Data and AI: Redefining Possibilities”, this event is set to explore the transformative potential of data and AI in shaping the future of the life sciences industry and healthcare delivery.

Organized by the Government of Telangana, the event will foster insightful discussions, interactive sessions, and networking opportunities that will collectively explore the potential opportunities data and AI can unleash for life sciences companies.

Mark your calendars for February 26-28, 2024, and join us in Hyderabad for BioAsia 2024 as we embark on a transformative journey to harness the power of data and AI, unlocking new possibilities and propelling the life sciences industry into a brighter future.

The theme for the 21st edition is ‘Transforming Life Sciences with Data and AI’.

D Sridhar Babu, Telangana Minister for Industries and Commerce, said that the 21st edition of  BioAsia would act as a catalyst and bring industry leaders together, exchange ideas, bring innovation and make Hyderabad the capital of life sciences in the world.

Telangana Industries Secretary Jayesh Ranjan said that the event would focus on partnerships, data-driven innovation, and accelerating research with AI.

“How best we can apply the use of Data and AI and the key takeaways from the event,” Shakthi Nagappan, Director of Life Sciences (Telangana) and CEO of BioAsia, said.

Over 3,000 delegates from over 50 countries attended the 20th edition.

Industries like G V Prasad (Managing Director and Co-Chairman of Dr Reddy’s Laboratories); Sharvil Patel (Managing Director, Zydus Cadila); and Toon Overstijns (Managing Director and Chairman of the Board, Miltenyi Biomedicine) would take part in the first panel discussion on ‘Now or never – Pushing the boundaries to become global drug discovery engine’.

“BioAsia focuses on driving growth of the industry by enabling an effective environment for fostering collaborations, joint ventures, mergers and acquisitions, and promote innovations. It will provide a platform for companies to showcase and launch their products and services,” a BioAsia 2024 spokesperson said.

Moving back to an in-person format, BioAsia 2024, Asia’s largest life-sciences and healthcare forum, will witness the participation of top personalities such as avid Ricks – CEO, Eli Lilly and Company; Geoff Martha – Chairman and CEO, Medtronic; Stefan Kaufmann – CEO, Olympus; and Arunish Chawla – Secretary, Department of Pharmaceuticals, Government of India.

Plant visits

Around 200 delegates, representing national and international companies, were taken in for a guided tour of the Genome Valley here on Monday in two groups. They visited IKP Knowledge Park (incubation centre) and Multitalented Facility Neovantage (Takshashila) to understand the facility and possible business prospects.

As part of the tour, the delegates were also shown around facilities of Bharat Biotech, Biological E Limited, and Sai Life Sciences in the Valley.

 

 

 

Blog By: Trupti Thakur